No Data
RAILY AESMED: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2024
Express News | Raily Aesthetic Medicine International Sees FY Loss Attributable of RMB59 Mln
The highest single transaction price exceeds 0.5 million yuan! The small peak in medical beauty before the festival "arrives as scheduled", and the differentiation of Institutions intensifies further | Fax.
① With the Spring Festival approaching, the medical beauty Industry is experiencing a small surge in Consumer spending, and medium to large medical beauty Institutions have recently seen a significant increase in customer flow. ② Hyaluronic acid, facial rejuvenation injections, and collagen, which have short recovery times and clear effects, remain the "favorites" of Consumers before the holiday. ③ The differentiation among medical beauty Institutions of different sizes is intensifying.
raily aesmed(02135.HK) has entered into a supply agreement with Suneva
Glory 15th November, raily aesmed (02135.HK) announced that on 24th January 2024, the company entered into a supply agreement with Suneva, under which the company will acquire distribution rights and equity. The supply agreement will remain valid until the 15th anniversary on 24th January 2024. After the initial period, upon mutual agreement between the company and Suneva, the supply agreement will be renewed for five years. Under the supply agreement, Suneva grants the company distribution rights in the Greater China region, granting exclusive rights to use, sell, tender sales, register, import, export, and commercialize Bellafill in the field of medical beauty.
Express News | Raily Aesthetic Medicine International - Supply Agreement Entered Between Company and Suneva
Express News | Raily Aesthetic Medicine International - Unit to Sell 100% Stkae in Shenzhen Jiumei Xinhe Medical Equipment for RMB3.7 Mln
Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Shares Climb 31% But Its Business Is Yet to Catch Up
